Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 EUR | +2.48% | -0.80% | +2.90% |
Apr. 22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
Apr. 11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.90% | 37.76M | |
+10.15% | 7.3B | |
-12.31% | 295M | |
-21.72% | 66.06M | |
-19.12% | 61.13M |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- US Consumer Advocacy Group Seeks to Strengthen Warnings on Botox Labeling